search
NASDAQ:CBAY
USD
32.48
- (0.03%)
CYMABAY THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 21 March 2024 GMT-4
USD 32.48
- (0.03%)
End of Day: 21 March 2024 GMT-4
Industry: Biotechnology

Quote

Market Cap
-
1M Daily Avg. Vol
-
3Y P/B Range
-
52W Range
-
3Y P/S Range
-
3Y DivYield Range
-

Company Info

more

CymaBay Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing therapies for patients with liver and other chronic diseases with high unmet medical need. Its product in p...

Key Ratios

more

Income

more

Balance Sheet

more

Cash Flow

more

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices